Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

150926 Press Releases
DateTitleCompany
26 Feb 16 Dicerna Reports Progress with GalNAc-DsiRNA-EX-Conjugates Dicerna ,
Published by
PharmiWeb.com
26 Feb 16 TxCell Announces Successful Key Milestone in the Technology Transfer To CMO Partner MaSTherCell And Updates On Ovasave® Clinical Trial Status TxCell ,
Published by
PharmiWeb.com
26 Feb 16 Knee Osteoarthritis: Autologous Conditioned Serum (ACS) Combined With Physiotherapy Led to Significant Improvement in Pain and Function Orthogen ,
Published by
PharmiWeb.com
26 Feb 16 Protein That Triggers Juvenile Arthritis Identified Albert Einstein College of Medicine,
Published by
PharmiWeb.com
26 Feb 16 New Study from Woodbury Psychology Chair Dr. Joye Swan Asks: 'Can Monogamy Actually Increase the Risk of HIV Infection?' Woodbury University,
Published by
PharmiWeb.com
26 Feb 16 Seattle Genetics Initiates Phase 1 Trial of SGN-CD19B for Patients with B-cell Non-Hodgkin Lymphoma Seattle Genetics ,
Published by
PharmiWeb.com
26 Feb 16 Biothera Announces Imprime PGG Positive Safety Findings and Pharmacokinetic Data from Two Phase 1 Studies, as Published in Investigational New Drugs: The Journal of New Anticancer Agents Biothera ,
Published by
PharmiWeb.com
26 Feb 16 ESTEVE and UAB Expand Their Research to Two New Gene Therapies for Sanfilippo B Syndrome and Hunter Syndrome ESTEVE,
Published by
PharmiWeb.com
26 Feb 16 Mauna Kea Technologies completes enrollment of 200 patient CONTACT II study on characterization of pancreatic cysts with needle-based confocal laser endomicroscopy Mauna Kea Technologies ,
Published by
PharmiWeb.com
26 Feb 16 Zynerba Pharmaceuticals Announces ZYN002 Granted Orphan Drug Designation for Fragile X Syndrome Zynerba Pharmaceuticals ,
Published by
PharmiWeb.com
26 Feb 16 Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia Rigel ,
Published by
PharmiWeb.com
26 Feb 16 ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir ViiV Healthcare ,
Published by
PharmiWeb.com
26 Feb 16 MOLOGEN AG: EMA supports development strategy of lefitolimod (MGN1703) MOLOGEN ,
Published by
PharmiWeb.com
26 Feb 16 European Medicines Agency Validates Gilead’s Marketing Application for Tenofovir Alafenamide (TAF) for the Treatment of Chronic Hepatitis B Gilead Sciences,
Published by
PharmiWeb.com
26 Feb 16 European CHMP Adopts Positive Opinion for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine/Tenofovir Alafenamide) for the Treatment of HIV Gilead Sciences,
Published by
PharmiWeb.com
26 Feb 16 Portage's Biohaven Announces Expedited Development Path for BHV-0223 Following Successful Pre-IND Interaction with FDA Portage's Biohaven ,
Published by
PharmiWeb.com
26 Feb 16 Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Keppra XR® Intellipharmaceutics ,
Published by
PharmiWeb.com
26 Feb 16 DATATRAK Appoints Interim CEO and President James Ward DATATRAK ,
Published by
PharmiWeb.com
26 Feb 16 Alkermes Announces Positive Topline Results From Clinical Study of Two-Month Dosing Option of ARISTADA® for Treatment of Schizophrenia Alkermes ,
Published by
PharmiWeb.com
26 Feb 16 Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in JAMA Otolaryngology Head & Neck Surgery Blaze Bioscience ,
Published by
PharmiWeb.com
26 Feb 16 New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations Boehringer Ingelheim ,
Published by
PharmiWeb.com
26 Feb 16 Portage's Biohaven announces positive results from phase 1 study with BHV-0223 Portage's Biohaven ,
Published by
PharmiWeb.com
26 Feb 16 Advanced Accelerator Applications Provides Update on Lutathera and Somakit Advanced Accelerator Applications ,
Published by
PharmiWeb.com
26 Feb 16 ESPERITE N.V. home Member State disclosure Esperite N.V.,
Published by
GlobeNewswire
26 Feb 16 Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date Published by
GlobeNewswire
26 Feb 16 FDA approves new indication for Novartis drug Afinitor® for progressive, nonfunctional GI and lung neuroendocrine tumors (NET) Novartis International AG,
Published by
GlobeNewswire
26 Feb 16 New targeted therapy for treatment of serious form of skin cancer approved in Canada Roche Canada ,
Published by
PharmiWeb.com
26 Feb 16 Most Ebola Survivors Examined in Study Experienced Brain Symptoms Six Months After Infection American Academy of Neurology,
Published by
PharmiWeb.com
26 Feb 16 Sleep Changes Seen With Fetal Alcohol Exposure Partly Explain Lifelong Learning And Mood Problems NYU Langone Medical Center,
Published by
PharmiWeb.com
26 Feb 16 True North Therapeutics Receives Orphan Drug Designation in the European Union for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, including Cold Agglutinin Disease (CAD) True North Therapeutics ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.